Celgene is now part of Bristol Myers Squibb creating a leading biopharma company positioned to help address the needs of patients with serious diseases. With effect from 1 June 2020 all new corporate giving funding requests will need to be requested via the BMS webpage – link here. If you have an existing request that is already in progress, this will be completed using the existing Celgene process and does not need to be resubmitted.

Date of Preparation: May 2020